Urine Cytology: Diagnostic Criteria, Correlation with Biopsy and an Emphasis on Ancillary Studies

Jordan P. Reynolds, MD
Assistant Professor of Pathology
Cleveland Clinic
Cleveland, Ohio
 

Urothelial carcinoma continues to be a leading cause of morbidity and mortality and urine cytology is useful for initial diagnosis and surveillance of these tumors. The Paris system of urinary cytology has proposed standardization of reporting urine cytology specimens. In addition to morphologic criteria, there are many ancillary studies that are used in urine cytology specimens for detection of neoplastic and non-neoplastic conditions. Examples include BK FISH in polyoma virus infection, and the multicolored probe set FISH (UroVysion), Immunocyt/uCyt+ and other markers.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Understand neoplastic and non neopastic cytology of the urinary tract
  • Discuss findings in high grade urothelial carcionma
  • Apply Paris criteria and terminology to urine cytology
  • Describe ancillary test modalities in urine cytology
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 MOC II
  • 2.00 Participant
Course opens: 
04/25/2017
Course expires: 
04/25/2020
Cost:
$105.00

Jordan P. Reynolds, MD
Assistant Professor of Pathology
Cleveland Clinic
Cleveland, OH

Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs.  All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  Click here for a complete list.

Presenter
Jordan P. Reynolds, MD

Disclosure
The presenter has no conflicts of interest or financial relationships to disclose.

 

ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process.  Earn up to 2.0 SAM Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 MOC II
  • 2.00 Participant

Accreditation Period

Course opens: 
04/25/2017
Course expires: 
04/25/2020

Price

Cost:
$105.00
Please login or register to take this course.